| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10157-018-1666-Z |
| P698 | PubMed publication ID | 30406500 |
| P2093 | author name string | Lin Zhao | |
| Jin He | |||
| Hua Gan | |||
| Xiaoyi Zhong | |||
| P2860 | cites work | Transforming growth factor-beta1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. | Q40404500 |
| The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor | Q41659068 | ||
| Clinical epidemiology of cardiovascular disease in chronic renal disease | Q43631482 | ||
| Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease | Q43700932 | ||
| Oxidative stress modulates osteoblastic differentiation of vascular and bone cells | Q43702897 | ||
| Modulation of the erythropoietin-induced proliferative pathway by cAMP in vascular smooth muscle cells. | Q44207547 | ||
| Skeletal effects of erythropoietin in hemodialysis patients | Q44908503 | ||
| Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. | Q64900894 | ||
| Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor | Q71163676 | ||
| Human recombinant erythropoietin inhibits interleukin-1beta-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells | Q77292152 | ||
| Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis | Q82222068 | ||
| Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo | Q83517528 | ||
| Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells | Q84638023 | ||
| Pulse wave velocity and vascular calcification at different stages of chronic kidney disease | Q84933519 | ||
| Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox | Q30471070 | ||
| Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway | Q33180653 | ||
| Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? | Q33345061 | ||
| Erythropoietin couples hematopoiesis with bone formation | Q33594296 | ||
| JAK2/STAT5/Bcl-xL signalling is essential for erythropoietin-mediated protection against apoptosis induced in PC12 cells by the amyloid β-peptide Aβ25-35. | Q33842736 | ||
| EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis | Q33864364 | ||
| Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes | Q33985838 | ||
| Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades | Q34086191 | ||
| TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. | Q34145009 | ||
| A current understanding of vascular calcification in CKD. | Q34355897 | ||
| Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease | Q34755816 | ||
| Direct effects of phosphate on vascular cell function | Q34910006 | ||
| Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling | Q35106750 | ||
| Erythropoietin (EPO) in acute kidney injury | Q35176135 | ||
| The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease | Q35693460 | ||
| Dual Delivery of EPO and BMP2 from a Novel Modular Poly-ɛ-Caprolactone Construct to Increase the Bone Formation in Prefabricated Bone Flaps | Q36006827 | ||
| Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression | Q36035490 | ||
| Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification | Q36309309 | ||
| The mechanism of erythropoietin action | Q36433253 | ||
| Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis | Q36476556 | ||
| Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. | Q36678487 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythropoietin | Q218706 |
| NF-κB | Q411114 | ||
| P304 | page(s) | 501-512 | |
| P577 | publication date | 2018-11-07 | |
| P1433 | published in | Clinical and experimental nephrology | Q26842022 |
| P1476 | title | JAK2/STAT3/BMP-2 axis and NF-κB pathway are involved in erythropoietin-induced calcification in rat vascular smooth muscle cells | |
| P478 | volume | 23 |
Search more.